| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |